The US Food and Drug Administration (FDA) will held a meeting this week for examining the possibility of authorizing booster shots of Moderna and Johnson and Johnson COVID-19 vaccines, Fox News reported on Wednesday.
It will set its decision upon the recommendations submitted to the agency by the US Centers of Disease Control and Prevention (CDC) which will hold its meeting within two weeks.
Until now, the issue of giving booster COVID-19 vaccine booster shots is still argumentative as there is a wide disagreement regarding which categories deserve to receive a booster shot.
Early this month, Johnson & Johnson officially requested from the FDA to authorize an extra shot to be added to the single-dose vaccine.
The Global Head of Research and Development at the international drug maker Mathai Mammen said: “Our clinical program has found that a booster of our Covid-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent.”
He explained that after the booster shot was given six months after essential dose “antibody levels increased nine-fold one week after the booster and continued to climb to 12-fold higher four weeks after the booster.”
“We look forward to our discussions with the FDA and other health authorities to support their decisions regarding boosters,” the expert concluded.
Last month, the US CDC officially approved booster COVID-19 vaccine doses to people who are in high risk.
The CDC board of experts recommended giving those extra shots to older people aged above 65 years old, nursing houses people, and persons who suffer from severe disease that could be developed by Coronavirus who were vaccinated by Pfizer COVID-19 vaccine.
However, the board rejected offering any booster shots to workers of medical professions, and health care workers.
The extra shot will be given six months after being fully vaccinated to increase the body’s immunity against the transmissible Delta variant.